Intelligent Bio Solutions Inc. (INBS) Notes Payables (2022 - 2025)
Intelligent Bio Solutions (INBS) posted quarterly Notes Payables of $197146.0 for Q2 2025, down 61.74% year-over-year from $515282.0 in Q2 2024, and down 44.65% quarter-over-quarter from $356156.0 in Q1 2025.
Intelligent Bio Solutions Inc. (INBS) Notes Payables (2022 - 2025) Analysis & Trends
Intelligent Bio Solutions' Notes Payables history runs 4 years deep, the most recent figure standing at $197146.0 for Q2 2025.
- In Q2 2025, Notes Payables fell 61.74% year-over-year to $197146.0; the TTM figure through Jun 2025 stood at $197146.0 (down 61.74% YoY), while the FY2025 annual figure was $197146.0, down 61.74% from the prior year.
- Notes Payables for Q2 2025 stood at $197146.0, down from $356156.0 in the prior quarter.
- The five-year high for Notes Payables was $523703.0 in Q4 2022, with the low at $197146.0 in Q2 2025.
- The 4-year median for Notes Payables is $368513.0 (2024), against an average of $387913.5.
- The sharpest annual moves came in 2024 and 2025: Notes Payables soared 46.15% in 2024, then tumbled 61.74% in 2025.
- Intelligent Bio Solutions' Notes Payables stood at $523703.0 in 2022, then retreated by 29.25% to $370535.0 in 2023, then grew by 9.45% to $405535.0 in 2024, then plunged by 51.39% to $197146.0 in 2025.
- Business Quant data shows INBS's Notes Payables at $197146.0 in Q2 2025, $356156.0 in Q1 2025, and $405535.0 in Q4 2024.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 197,146.00 |
| Mar 31, 2025 | 356,156.00 |
| Dec 31, 2024 | 405,535.00 |
| Sep 30, 2024 | 499,605.00 |
| Jun 30, 2024 | 515,282.00 |
| Mar 31, 2024 | 368,513.00 |
| Dec 31, 2023 | 370,535.00 |
| Sep 30, 2023 | 341,834.00 |
| Jun 30, 2023 | 353,211.00 |
| Mar 31, 2023 | 335,528.00 |
| Dec 31, 2022 | 523,703.00 |